ProteinQure Inc. | WebDisclosure

Basculer en Français

8553	Companies
135573	Keywords
71946	Articles
72386	Press releases

Home
Companies
ProteinQure Inc.

BRIEF

published on 01/07/2025 at 16:50, 2 months 4 days ago

ProteinQure Strengthens Leadership Team with Strategic Appointments

Clinical Development Leadership Appointments ProteinQure PQ203 Peptide Therapeutics
BRIEF

published on 01/07/2025 at 16:50, 2 months 4 days ago

ProteinQure renforce son équipe de direction avec des nominations stratégiques

Développement Clinique Nominations À La Direction PQ203 ProtéineQure Thérapeutique À Base De Peptides
PRESS RELEASE

published on 01/07/2025 at 16:45, 2 months 4 days ago

ProteinQure Strengthens Leadership Team with Key Appointments to Accelerate Translational and Clinical Development Programs
ProteinQure strengthens team with key hires, including Dr. Dave Garman as VP of Translation and Development, and Dr. Edward Garmey as consulting CMO. Focus on advancing clinical asset PQ203 for triple negative breast cancer

ProteinQure Breast Cancer PQ203 Team Clinical Asset
BRIEF

published on 12/06/2024 at 18:35, 3 months 4 days ago

ProteinQure to Unveil New Data on PQ203 at San Antonio Symposium

Clinical Trials Drug Development ProteinQure Breast Cancer PQ203
BRIEF

published on 12/06/2024 at 18:35, 3 months 4 days ago

ProteinQure dévoilera de nouvelles données sur PQ203 lors du symposium de San Antonio

Essais Cliniques Développement De Médicaments Cancer Du Sein PQ203 ProtéineQure
PRESS RELEASE

published on 12/06/2024 at 18:30, 3 months 4 days ago

ProteinQure to Present Data on PQ203, a Novel Peptide-Drug Conjugate for Triple Negative Breast Cancer, at 2024 San Antonio Breast Cancer Symposium
ProteinQure to present promising data on PQ203, a peptide drug conjugate for TNBC treatment, at 2024 San Antonio Breast Cancer Symposium. Phase 1 trial in 2025

Clinical Trials ProteinQure TNBC Breast Cancer PQ203
BRIEF

published on 03/25/2024 at 05:06, 11 months 17 days ago

ProteinQure Unveils Breakthrough Peptide Drug Conjugate for Triple-Negative Breast Cancer

ProteinQure TNBC PDX Models Computational Drug Design AACR Conference
BRIEF

published on 03/25/2024 at 05:06, 11 months 17 days ago

ProteinQure dévoile un conjugué peptidique-médicament révolutionnaire pour le cancer du sein triple négatif

TNBC ProtéineQuure Modèles PDX Conception Informatique De Médicaments Conférence AACR
PRESS RELEASE

published on 03/25/2024 at 05:01, 11 months 17 days ago

ProteinQure Announces A Breakthrough Therapeutic with Remarkable Efficacy in Heterogenous Patient-Derived Xenograft Models of Triple-Negative Breast Cancer to be presented at AACR
ProteinQure announces breakthrough in triple-negative breast cancer treatment through novel Peptide Drug Conjugate with exceptional efficacy in lab experiments

Clinical Trial ProteinQure Computational Drug Design Peptide Drug Conjugate Breast Cancer Treatment
PRESS RELEASE

published on 06/26/2023 at 17:10, 1 year 8 months ago

ProteinQure Inc. Announces Robust Preclinical Efficacy in a Triple Negative Breast Cancer Mouse Tumour Model Study

Accesswire

Published on 03/11/2025 at 16:00, 1 hour 44 minutes ago

D. Boral Capital Served as Exclusive Placement Agent to Plus Therapeutics, Inc. (Nasdaq:PSTV) in Connection with its up to $15.0 Million Private Placement
Published on 03/11/2025 at 15:15, 2 hours 29 minutes ago

ACCESS Newswire Inc. to Host Fourth Quarter and FY 2024 Earnings Conference Call on March 25, 2025
Published on 03/11/2025 at 14:40, 3 hours 4 minutes ago

Organto Foods to Resume Trading on the TSX Venture Exchange
Published on 03/11/2025 at 14:25, 3 hours 19 minutes ago

Highlander Silver Closes $32 Million Bought Deal Private Placement
Published on 03/11/2025 at 14:00, 3 hours 44 minutes ago

Amdocs to Participate in Investor Webinar Hosted by J.P. Morgan Equity Research

View all ACCESSWIRE

EQS Group

Published on 03/11/2025 at 16:59, 44 minutes ago

Director/PDMR Shareholding
Published on 03/11/2025 at 16:45, 58 minutes ago

EQS-Adhoc: STRABAG SE: After expiration of deadline: further negotiations of transaction to acquire parts of VAMED Group
Published on 03/11/2025 at 15:12, 2 hours 31 minutes ago

North Peak Engages ICP Securities for Automated Market Making Services
Published on 03/11/2025 at 15:00, 2 hours 44 minutes ago

Director/PDMR Shareholding*
Published on 03/11/2025 at 14:53, 2 hours 51 minutes ago

Amundi Physical Metals plc: UK Final Terms

Les Echos

Published on 03/11/2025 at 09:14, 8 hours 29 minutes ago

Nombre total d'actions et droits de vote - Février 2025
Published on 03/11/2025 at 09:14, 8 hours 29 minutes ago

Number of shares and voting rights - February 2025 (In French only)
Published on 03/11/2025 at 08:30, 9 hours 14 minutes ago

Cie du Bois Sauvage: Terugkoop van eigen aandelen – Week van 03/03/2025 tot 07/03/2025
Published on 03/11/2025 at 08:30, 9 hours 14 minutes ago

Cie du Bois Sauvage : Rachat d’actions propres – semaine du 03/03/2025 au 07/03/2025
Published on 03/11/2025 at 08:30, 9 hours 14 minutes ago

Cie du Bois Sauvage: Buy back of own shares – week from 03/03/2025 to 07/03/2025

View all LES ECHOS COMFI WIRE